1
|
Powers AM and Logue CH: Changing patterns
of chikungunya virus: Re-emergence of a zoonotic arbovirus. J Gen
Virol. 88:2363–2377. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Caglioti C, Lalle E, Castilletti C,
Carletti F, Capobianchi MR and Bordi L: Chikungunya virus
infection: An overview. New Microbiol. 36:211–227. 2013.PubMed/NCBI
|
3
|
Goupil BA and Mores CN: A review of
Chikungunya virus-induced arthralgia: Clinical manifestations,
therapeutics, and pathogenesis. Open Rheumatol J. 10:129–140.
2016.PubMed/NCBI
|
4
|
Sepúlveda-Delgado J, Vera-Lastra OL,
Trujillo-Murillo K, Canseco-Ávila LM, Sánchez-González RA,
Gómez-Cruz O, Lugo-Trampe A, Fernández-Salas I, Danis-Lozano R,
Contreras-Contreras A, et al: Inflammatory biomarkers, disease
activity index, and self-reported disability may be predictors of
chronic arthritis after chikungunya infection: brief report. Clin
Rheumatol. 36:695–699. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kucharz EJ and Cebula-Byrska I:
Chikungunya fever. Eur J Intern Med. 23:325–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Rodriguez-Morales AJ, Villamil-Gomez W,
Merlano-Espinosa M and Simone-Kleber L: Post-chikungunya chronic
arthralgia: a first retrospective follow-up study of 39 cases in
Colombia. Clin Rheumatol. 35:831–832. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Murillo-Zamora E, Mendoza-Cano O,
Trujillo-Hernández B, Alberto Sánchez-Piña R and Guzmán-Esquivel J:
Persistent arthralgia and related risks factors in
laboratory-confirmed cases of Chikungunya virus infection in
Mexico. Rev Panam Salud Publica. 41:e722017.PubMed/NCBI
|
8
|
Economopoulou A, Dominguez M, Helynck B,
Sissoko D, Wichmann O, Quenel P, Germonneau P and Quatresous I:
Atypical Chikungunya virus infections: clinical manifestations,
mortality and risk factors for severe disease during the 2005–2006
outbreak on Réunion. Epidemiol Infect. 137:534–541. 2009.
View Article : Google Scholar : PubMed/NCBI
|
9
|
van Aalst M, Nelen CM, Goorhuis A, Stijnis
C and Grobusch MP: Long-term sequelae of chikungunya virus disease:
A systematic review. Travel Med Infect Dis. 15:8–22. 2017.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Thanapati S, Ganu M, Giri P, Kulkarni S,
Sharma M, Babar P, Ganu A and Tripathy AS: Impaired NK cell
functionality and increased TNF-α production as biomarkers of
chronic chikungunya arthritis and rheumatoid arthritis. Hum
Immunol. 78:370–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chow A, Her Z, Ong EK, Chen JM, Dimatatac
F, Kwek DJ, Barkham T, Yang H, Rénia L, Leo YS and Ng LF:
Persistent arthralgia induced by Chikungunya virus infection is
associated with interleukin-6 and granulocyte macrophage
colony-stimulating factor. J Infect Dis. 203:149–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Narazaki M, Tanaka T and Kishimoto T: The
role and therapeutic targeting of IL-6 in rheumatoid arthritis.
Expert Rev Clin Immunol. 13:535–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Englbrecht M, Tarner IH, van der Heijde
DM, Manger B, Bombardier C and Müller-Ladner U: Measuring pain and
efficacy of pain treatment in inflammatory arthritis: A systematic
literature review. J Rheumatol. 90:3–10. 2012.
|
14
|
Food and Drug Administration, . Emergency
Use Authorizations. Trioplex real-time RT-PCR assay (CDC).
2016.https://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496#zikaMay
11–2017
|
15
|
Pincus T, Yazici Y and Bergman MJ: RAPID3,
an index to assess and monitor patients with rheumatoid arthritis,
without formal joint counts: Similar results to DAS28 and CDAI in
clinical trials and clinical care. Rheum Dis Clin North Am.
35:773–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Palos GR, Mendoza TR, Mobley GM, Cantor SB
and Cleeland CS: Asking the community about cutpoints used to
describe mild, moderate, and severe pain. J Pain. 7:49–56. 2006.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Serlin RC, Mendoza TR, Nakamura Y, Edwards
KR and Cleeland CS: When is cancer pain mild, moderate or severe?
Grading pain severity by its interference with function. Pain.
61:277–284. 1995. View Article : Google Scholar : PubMed/NCBI
|
18
|
Boonstra AM, Stewart RE, Köke AJA,
Oosterwijk RFA, Swaan JL, Schreurs KMG and Preuper HRS: Cut-off
points for mild, moderate, and severe pain on the numeric rating
scale for pain in patients with chronic musculoskeletal pain:
Variability and influence of sex and catastrophizing. Front
Psychol. 7:14662016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Jones KR, Vojir CP, Hutt E and Fink R:
Determining mild, moderate, and severe pain equivalency across
pain-intensity tools in nursing home residents. J Rehabil Res Dev,.
44:305–314. 2007. View Article : Google Scholar
|
20
|
Zelman DC, Hoffman DL, Seifeldin R and
Dukes EM: Development of a metric for a day of manageable pain
control: Derivation of pain severity cut-points for low back pain
and osteoarthritis. Pain. 106:35–42. 2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Aicher B, Peil H, Peil B and Diener HC:
Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating
Scale (VRS) in clinical trials with OTC analgesics in headache.
Cephalalgia. 32:185–197. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Taype-Rondan A, Bernabe-Ortiz A, Alvarado
GF, Gilman RH, Smeeth L and Miranda JJ: Smoking and heavy drinking
patterns in rural, urban and rural-to-urban migrants: The PERU
MIGRANT Study. BMC Public Health. 17:1652017. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bondy SJ, Victor JC and Diemert LM: Origin
and use of the 100 cigarette criterion in tobacco surveys. Tob
Control. 18:317–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Tervo L, Mäkelä S, Syrjänen J, Huttunen R,
Rimpelä A, Huhtala H, Vapalahti O, Vaheri A and Mustonen J: Smoking
is associated with aggravated kidney injury in Puumala
hantavirus-induced haemorrhagic fever with renal syndrome. Nephrol
Dial Transplant. 30:1693–1698. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Çörtük M, Acat M, Yazici O, Yasar Z, Kiraz
K, Ataman SY, Tanriverdi E, Zitouni B, Kirakli C, Ediboglu O, et
al: Retrospective review of epidemic viral pneumonia cases in
Turkey: A multicenter study. Exp Ther Med. 13:1431–1437. 2017.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Groskreutz DJ, Monick MM, Babor EC,
Nyunoya T, Varga SM, Look DC and Hunninghake GW: Cigarette smoke
alters respiratory syncytial virus-induced apoptosis and
replication. Am J Respir Cell Mol Biol. 41:189–198. 2009.
View Article : Google Scholar : PubMed/NCBI
|
27
|
McGrath-Morrow S, Rangasamy T, Cho C,
Sussan T, Neptune E, Wise R, Tuder RM and Biswal S: Impaired lung
homeostasis in neonatal mice exposed to cigarette smoke. Am J
Respir Cell Mol Biol. 38:393–400. 2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Azzopardi D, Haswell LE, Foss-Smith G,
Hewitt K, Asquith N, Corke S and Phillips G: Evaluation of an
air-liquid interface cell culture model for studies on the
inflammatory and cytotoxic responses to tobacco smoke aerosols.
Toxicol In Vitro. 29:1720–1728. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Husari A, Shihadeh A, Talih S, Hashem Y,
El Sabban M and Zaatari G: Acute exposure to electronic and
combustible cigarette aerosols: Effects in an animal model and in
human alveolar cells. Nicotine Tob Res. 18:613–619. 2016.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Borges ÁH, O'Connor JL, Phillips AN,
Rönsholt FF, Pett S, Vjecha MJ, French MA, Lundgren JD, et al:
Factors associated with plasma IL-6 levels during HIV infection. J
Infect Dis. 212:585–595. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Nadrowski P, Chudek J, Skrzypek M,
Puzianowska-Kuźnicka M, Mossakowska M, Więcek A, Zdrojewski T,
Grodzicki T and Kozakiewicz K: Associations between cardiovascular
disease risk factors and IL-6 and hsCRP levels in the elderly. Exp
Gerontol. 85:112–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Nakanishi K, Nishida M, Harada M, Ohama T,
Kawada N, Murakami M, Moriyama T and Yamauchi-Takiharaa K:
Klotho-related molecules upregulated by smoking habit in apparently
healthy men: A cross-sectional study. Sci Rep. 5:142302015.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Sopori ML and Kozak W: Immunomodulatory
effects of cigarette smoke. J Neuroimmunol. 83:148–156. 1998.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Miner JJ, Aw-Yeang HX, Fox JM, Taffner S,
Malkova ON, Oh ST, Kim AHJ, Diamond MS, Lenschow DJ and Yokoyama
WM: Chikungunya viral arthritis in the United States: A mimic of
seronegative rheumatoid arthritis. Arthritis Rheumatol.
67:1214–1220. 2015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Baillet A, Gossec L, Paternotte S, Etcheto
A, Combe B, Meyer O, Mariette X, Gottenberg JE and Dougados M:
Evaluation of serum interleukin-6 level as a surrogate marker of
synovial inflammation and as a factor of structural progression in
early rheumatoid arthritis: Results from a French national
multicenter cohort. Arthritis Care Res (Hoboken). 67:905–912. 2015.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Van Keulen HV, Gomes AS, Toffolo MC,
Oliveira EE, Silva LC, Alves CC, Almeida CS, Dutra SC, Aguiar AS
and Ferreira AP: Serum levels of nitric oxide and cytokines in
smokers at the beginning and after 4months of treatment for smoking
cessation. Int J Cardiol. 230:327–331. 2017. View Article : Google Scholar : PubMed/NCBI
|
37
|
van Aalst M, Nelen CM, Goorhuis A, Stijnis
C and Grobusch MP: Long-term sequelae of chikungunya virus disease:
A systematic review. Travel Med Infect Dis. 15:8–22. 2017.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Svensson B, Andersson M, Forslind K,
Ajeganova S and Hafström I; BARFOT study group, : Persistently
active disease is common in patients with rheumatoid arthritis,
particularly in women: a long-term inception cohort study. Scand J
Rheumatol. 45:448–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
39
|
Wegner A, Benson S, Rebernik L, Spreitzer
I, Jäger M, Schedlowski M, Elsenbruch S and Engler H: Sex
differences in the pro-inflammatory cytokine response to endotoxin
unfold in vivo but not ex vivo in healthy humans. Innate Immun.
23:432–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
40
|
Sugiyama D, Nishimura K, Tamaki K, Tsuji
G, Nakazawa T, Morinobu A and Kumagai S: Impact of smoking as a
risk factor for developing rheumatoid arthritis: a meta-analysis of
observational studies. Ann Rheum Dis. 69:70–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
41
|
Ruban TN, Jacob B, Pope JE, Keystone EC,
Bombardier C and Kuriya B: The influence of age at disease onset on
disease activity and disability: Results from the ontario best
practices research initiative. Clin Rheumatol. 35:759–763. 2016.
View Article : Google Scholar : PubMed/NCBI
|
42
|
Sebastiani P, Thyagarajan B, Sun F, Honig
LS, Schupf N, Cosentino S, Feitosa MF, Wojczynski M, Newman AB,
Montano M and Perls TT: Age and sex distributions of age-related
biomarker values in healthy older adults from the long life family
study. J Am Geriatr Soc. 64:e189–e194. 2016. View Article : Google Scholar : PubMed/NCBI
|
43
|
Schilte C, Staikowsky F, Couderc T, Madec
Y, Carpentier F, Kassab S, Albert ML, Lecuit M and Michault A:
Chikungunya virus-associated long-term arthralgia: A 36-month
prospective longitudinal study. PLoS Negl Trop Dis. 7:e21372013.
View Article : Google Scholar : PubMed/NCBI
|
44
|
Yaseen HM, Simon F, Deparis X and
Marimoutou C: Identification of initial severity determinants to
predict arthritis after chikungunya infection in a cohort of French
gendarmes. BMC Musculoskelet Disord. 15:2492014. View Article : Google Scholar : PubMed/NCBI
|
45
|
Abdelnabi R, Neyts J and Delang L:
Chikungunya virus infections: Time to act, time to treat. Curr Opin
Virol. 24:25–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
46
|
Blettery M, Brunier L, Polomat K, Moinet
F, Deligny C, Arfi S, Jean-Baptiste G and De Bandt M: Brief report:
Management of chronic post-chikungunya rheumatic disease: The
martinican experience. Arthritis Rheumatol. 68:2817–2824. 2016.
View Article : Google Scholar : PubMed/NCBI
|
47
|
World Health Organization, . Guidelines on
Clinical Management of Chikungunya Fever. http://www.wpro.who.int/mvp/topics/ntd/Clinical_Mgnt_Chikungunya_WHO_SEARO.pdfOct
10–2017
|